Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
| Autor: | Aaliya Taiyab, Asimul Islam, Preeti Gupta, Mohamed F. Alajmi, Afzal Hussain, Md. Imtaiyaz Hassan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Cancer Research Ceramide Sphingosine kinase Review lcsh:RC254-282 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine kinase inhibitors drug design and discovery Sphingosine-1-phosphate Receptor Sphingosine Cell growth Cancer medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Sphingolipid Cell biology 030104 developmental biology Oncology chemistry sphingosine kinase 030220 oncology & carcinogenesis cancer therapy lipids (amino acids peptides and proteins) sphingosine metabolism |
| Zdroj: | Cancers Cancers, Vol 13, Iss 1898, p 1898 (2021) |
| ISSN: | 2072-6694 |
| Popis: | Simple Summary Cancer is the prime cause of death globally. The altered stimulation of signaling pathways controlled by human kinases has often been observed in various human malignancies. The over-expression of SphK1 (a lipid kinase) and its metabolite S1P have been observed in various types of cancer and metabolic disorders, making it a potential therapeutic target. Here, we discuss the sphingolipid metabolism along with the critical enzymes involved in the pathway. The review provides comprehensive details of SphK isoforms, including their functional role, activation, and involvement in various human malignancies. An overview of different SphK inhibitors at different phases of clinical trials and can potentially be utilized as cancer therapeutics has also been reviewed. Abstract Sphingolipid metabolites have emerged as critical players in the regulation of various physiological processes. Ceramide and sphingosine induce cell growth arrest and apoptosis, whereas sphingosine-1-phosphate (S1P) promotes cell proliferation and survival. Here, we present an overview of sphingolipid metabolism and the compartmentalization of various sphingolipid metabolites. In addition, the sphingolipid rheostat, a fine metabolic balance between ceramide and S1P, is discussed. Sphingosine kinase (SphK) catalyzes the synthesis of S1P from sphingosine and modulates several cellular processes and is found to be essentially involved in various pathophysiological conditions. The regulation and biological functions of SphK isoforms are discussed. The functions of S1P, along with its receptors, are further highlighted. The up-regulation of SphK is observed in various cancer types and is also linked to radio- and chemoresistance and poor prognosis in cancer patients. Implications of the SphK/S1P signaling axis in human pathologies and its inhibition are discussed in detail. Overall, this review highlights current findings on the SphK/S1P signaling axis from multiple angles, including their functional role, mechanism of activation, involvement in various human malignancies, and inhibitor molecules that may be used in cancer therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|